Men's Journal reports the coroner's findings on the cause of Norton's death, with the dose detail coming from the coroner rather than earlier speculation.
Recap by typeshit. Full story at Men's Journal.
A shared explainer on how eating habits and food choices matter once you begin a GLP-1 medication. General guidance, no new findings.
Williams explains how retatrutide's glucagon pathway works and cautions that knockoff Reta sold online is a real risk. FDA approval could come in late 2027 or 2028.
A brief post argues buyers need accurate information on peptides because a lot of the popular messaging is misleading.
Coroner David Ryan found Norton had been taking double his prescribed dose and urged Australia's TGA to tighten rules on peptides, limiting them to clinical trials.
With 30% of covering employers weighing cuts, Wegovy and Zepbound users should check their plans now. Includes current self-pay prices and tips for appeals.
Yaccarino argues the drugs help employers' bottom line as well as waistlines. It's an opinion post, with no data attached to back the claim.
Loading…